Peizhong Ni

Title: Peizhong Ni: Innovator in KRAS Inhibition

Introduction

Peizhong Ni is a notable inventor based in Shanghai, China. He has made significant contributions to the field of biopharmaceuticals, particularly in the development of compounds that target KRAS, a critical protein involved in cancer progression. His innovative work has the potential to impact cancer treatment significantly.

Latest Patents

Peizhong Ni holds a patent for "Cycloalkyl and hetero-cycloalkyl inhibitors, preparation methods therefor, and use thereof." This patent describes compounds with a structure represented by formula (I). The invention details preparation methods for these compounds and their application as KRAS inhibitors. The compounds exhibit an excellent ability to selectively inhibit KRAS, along with improved pharmacodynamic and pharmacokinetic performance, while also reducing toxic side effects. He has 1 patent to his name.

Career Highlights

Throughout his career, Peizhong Ni has worked with prominent companies in the biopharmaceutical sector. Notably, he has been associated with Suzhou Zelgen Biopharmaceuticals Co., Ltd. and Shanghai Zelgen Pharma Technology Co., Ltd. His work in these organizations has contributed to advancements in drug development and therapeutic solutions.

Collaborations

Peizhong Ni has collaborated with several professionals in his field, including Binhua Lv and Dawei Cui. These collaborations have fostered innovation and enhanced the research and development of new therapeutic compounds.

Conclusion

Peizhong Ni's contributions to the field of biopharmaceuticals, particularly in KRAS inhibition, highlight his role as an influential inventor. His work continues to pave the way for advancements in cancer treatment and therapeutic development.